Compare NBTX & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | RLJ |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2018 | 2011 |
| Metric | NBTX | RLJ |
|---|---|---|
| Price | $38.05 | $11.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $36.00 | $7.83 |
| AVG Volume (30 Days) | 119.2K | ★ 1.9M |
| Earning Date | 03-31-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 7.26% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $1,349,860,000.00 |
| Revenue This Year | $58.17 | $2.02 |
| Revenue Next Year | N/A | $2.54 |
| P/E Ratio | ★ N/A | $91.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.03 | $6.54 |
| 52 Week High | $57.14 | $12.89 |
| Indicator | NBTX | RLJ |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 37.32 |
| Support Level | $34.83 | $7.24 |
| Resistance Level | $41.99 | $12.11 |
| Average True Range (ATR) | 1.99 | 0.41 |
| MACD | -0.09 | -0.19 |
| Stochastic Oscillator | 51.22 | 16.06 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.